The Searle Company Limited (PSX:SEARL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
91.16
-1.57 (-1.69%)
At close: Apr 28, 2026
17.80%
Market Cap 53.62B
Revenue (ttm) 33.26B
Net Income (ttm) 358.56M
Shares Out 588.22M
EPS (ttm) 0.61
PE Ratio 29.45
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 866,794
Average Volume 3,950,173
Open 90.50
Previous Close 92.73
Day's Range 90.50 - 92.45
52-Week Range 52.75 - 137.44
Beta 0.47
RSI 49.00
Earnings Date Apr 29, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa... [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 1965
Employees 3,799
Stock Exchange Pakistan Stock Exchange
Ticker Symbol SEARL
Full Company Profile

Financial Performance

In fiscal year 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.

Financial Statements

News

There is no news available yet.